Pharmaceutical

AbbVie and Tentarix enter biologic development deal

AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and develop biologic candidates in oncology and immunology.

Feb 24, 2024 - 18:00
AbbVie and Tentarix enter biologic development deal
AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and develop biologic candidates in oncology and immunology.
Read the original article

Tags:

Previous Article

AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

Next Article

AstraZeneca’s Tagrisso-Chemo Combination Bags FDA Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

RJ Reynolds is threatening to sue vape shops for selling flavored vapes

RJ Reynolds is threatening to sue vape shops for sellin...

May 3, 2023

FDA lifts clinical hold on PepGen’s myotonic dystrophy type 1 candidate

FDA lifts clinical hold on PepGen’s myotonic dystrophy ...

Oct 13, 2023

FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension

FDA approves J&J’s OPSYNVI for pulmonary arterial hyper...

Mar 26, 2024